• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pharmacol Rep . Health-related quality of life in survivors of severe COVID-19 infection

tetano

Editor, Senior Moderator
Pharmacol Rep


. 2022 Nov 14.
doi: 10.1007/s43440-022-00433-5. Online ahead of print.
Health-related quality of life in survivors of severe COVID-19 infection


Gabriele d'Ettorre[SUP] 1 [/SUP], Paolo Vassalini[SUP] 2 [/SUP], Vincenzo Coppolelli[SUP] 2 [/SUP], Elio Gentilini Cacciola[SUP] 2 [/SUP], Letizia Sanitinelli[SUP] 2 [/SUP], Luca Maddaloni[SUP] 2 [/SUP], Silvia Fabris[SUP] 3 [/SUP], Claudio M Mastroianni[SUP] 2 [/SUP], Gabriella d'Ettorre[SUP] 2 [/SUP], Giancarlo Ceccarelli[SUP] 4 5 [/SUP]



Affiliations

Abstract

Background: Long-term effects of Coronavirus Disease 2019 (COVID-19) are increasingly recognized as having a significant impact on Health-Related Quality of Life (HRQoL). Understanding HRQoL status for each patient affected by long COVID-19 and its determinants may have a key role to prevent and treat this condition.
Methods: In this prospective observational study conducted in a large academic COVID-19 hospital in Rome, participants were contacted 2 years after hospital admission for severe COVID-19. To assess HRQoL, EQ-5D-5L and Visual analog scale (EQ VAS) standard questionnaires were administered by interview. Logistic regression model was used to the five health dimensions as dependent variables (0 = no problem, 1 = some/extreme problem).
Key results: In 137 enrolled patients, the mean pre-COVID and post-COVID EQ-5D-5L index and EQ-VAS score were 0.97 (SD 0.06), 0.79 (SD 0.26) and 72.38 (SD 15.18), respectively. After subdivision of the participants for clinical and social variables, the EQ-5D-5L index resulted significantly lower than in the pre-COVID-19 period. Female gender, unemployed status, and chronic comorbidities were the most common predictors for having any problems in each EQ-5D-5L domain, while also older age and higher Body Mass Index (BMI) showed to be related to a lower EQ-VAS score.
Conclusion: HRQoL showed to be still low in patients 2 years after acute severe COVID-19. Given the significant impact of SARS-CoV-2 on long-term chronic symptoms, predictors of poor outcomes must be considered during the acute phase of illness to plan a tailored follow-up path for each patient.

Keywords: COVID-19; HRQoL; Health-related quality of life; Post-COVID; Quality of life; SARS-CoV2.
 
Back
Top Bottom